Baotou Dongbao Bio-TechLtd (300239) Stock Overview
Engages in the design, research and development, production, and sale of gelatin and collagen in the People’s Republic of China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Risk Analysis
No risks detected for 300239 from our risk checks.
300239 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Baotou Dongbao Bio-Tech Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥4.83 |
| 52 Week High | CN¥6.82 |
| 52 Week Low | CN¥4.59 |
| Beta | 0.16 |
| 1 Month Change | -11.38% |
| 3 Month Change | -18.82% |
| 1 Year Change | -13.75% |
| 3 Year Change | -22.97% |
| 5 Year Change | -22.60% |
| Change since IPO | -6.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300239 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | -2.8% | 3.1% | -1.5% |
| 1Y | -13.8% | 58.4% | 27.7% |
Return vs Industry: 300239 underperformed the CN Chemicals industry which returned 58.4% over the past year.
Return vs Market: 300239 underperformed the CN Market which returned 27.7% over the past year.
Price Volatility
| 300239 volatility | |
|---|---|
| 300239 Average Weekly Movement | 5.3% |
| Chemicals Industry Average Movement | 7.0% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.5% |
| 10% least volatile stocks in CN Market | 4.4% |
Stable Share Price: 300239 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300239's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1960 | 1,424 | Fang Liu | www.dongbaoshengwu.com |
Baotou Dongbao Bio-Tech Co.,Ltd engages in the design, research and development, production, and sale of gelatin and collagen in the People’s Republic of China and internationally. It offers pharmaceutical gelation, food additives gelatin, and photographic gelatin; hydrolyzed collagen, collagen peptide, fish collagen peptide, and agglomerated collagen; and private label collagen and unflavored collagen jars. The company also provides organic fertilizers, water soluble fertilizers, and compound microbial fertilizers; and industrial grade calcium hydrogen phosphate and feed grade calcium hydrogen phosphate.
Baotou Dongbao Bio-Tech Co.,Ltd Fundamentals Summary
| 300239 fundamental statistics | |
|---|---|
| Market cap | CN¥2.82b |
| Earnings (TTM) | CN¥54.99m |
| Revenue (TTM) | CN¥747.80m |
Is 300239 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300239 income statement (TTM) | |
|---|---|
| Revenue | CN¥747.80m |
| Cost of Revenue | CN¥590.70m |
| Gross Profit | CN¥157.10m |
| Other Expenses | CN¥102.12m |
| Earnings | CN¥54.99m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.094 |
| Gross Margin | 21.01% |
| Net Profit Margin | 7.35% |
| Debt/Equity Ratio | 29.0% |
How did 300239 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/13 19:39 |
| End of Day Share Price | 2026/06/12 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Baotou Dongbao Bio-Tech Co.,Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jie Yao | Everbright Securities Co. Ltd. |